ContraFect Corporation

OTCPK:CFRX Stock Report

Market Cap: US$676.1k

ContraFect Management

Management criteria checks 3/4

ContraFect's El consejero delegado es Mike Messinger , nombrado en Nov 2018, tiene un mandato de 5.08 años. la remuneración anual total es $957.21K , compuesta por 42.9% salario y 57.1% primas, incluidas acciones y opciones de la empresa. posee directamente 0% de las acciones de la empresa, por valor de $1.42 . La antigüedad media del equipo directivo y del consejo de administración es de 2.5 años y 9.7 años respectivamente.

Key information

Mike Messinger

Chief executive officer

US$957.2k

Total compensation

CEO salary percentage42.9%
CEO tenure5.1yrs
CEO ownership0.0002%
Management average tenure2.5yrs
Board average tenure9.7yrs

Recent management updates

Recent updates

Contrafect GAAP EPS of -$0.46 misses by $0.13

Aug 15

ContraFect sinks ~76% as data safety board recommends ending co's DISRUPT trial

Jul 13

ContraFect (NASDAQ:CFRX) Is In A Good Position To Deliver On Growth Plans

Jun 29
ContraFect (NASDAQ:CFRX) Is In A Good Position To Deliver On Growth Plans

Is ContraFect (NASDAQ:CFRX) In A Good Position To Invest In Growth?

Dec 25
Is ContraFect (NASDAQ:CFRX) In A Good Position To Invest In Growth?

ContraFect: Non-Antibiotic Alternative That Could Disrupt The Antibiotic Market

Sep 15

We're Keeping An Eye On ContraFect's (NASDAQ:CFRX) Cash Burn Rate

Aug 18
We're Keeping An Eye On ContraFect's (NASDAQ:CFRX) Cash Burn Rate

Is ContraFect (NASDAQ:CFRX) In A Good Position To Deliver On Growth Plans?

May 01
Is ContraFect (NASDAQ:CFRX) In A Good Position To Deliver On Growth Plans?

Are Institutions Heavily Invested In ContraFect Corporation's (NASDAQ:CFRX) Shares?

Mar 09
Are Institutions Heavily Invested In ContraFect Corporation's (NASDAQ:CFRX) Shares?

Is ContraFect (NASDAQ:CFRX) In A Good Position To Invest In Growth?

Jan 15
Is ContraFect (NASDAQ:CFRX) In A Good Position To Invest In Growth?

What Type Of Shareholders Make Up ContraFect Corporation's (NASDAQ:CFRX) Share Registry?

Nov 24
What Type Of Shareholders Make Up ContraFect Corporation's (NASDAQ:CFRX) Share Registry?

Contrafect EPS beats by $0.16

Nov 13

CEO Compensation Analysis

How has Mike Messinger's remuneration changed compared to ContraFect's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2023n/an/a

-US$24m

Jun 30 2023n/an/a

-US$36m

Mar 31 2023n/an/a

-US$46m

Dec 31 2022US$957kUS$410k

-US$65m

Sep 30 2022n/an/a

-US$60m

Jun 30 2022n/an/a

-US$48m

Mar 31 2022n/an/a

-US$35m

Dec 31 2021US$883kUS$389k

-US$20m

Sep 30 2021n/an/a

-US$22m

Jun 30 2021n/an/a

-US$14m

Mar 31 2021n/an/a

-US$26m

Dec 31 2020US$1mUS$374k

-US$28m

Sep 30 2020n/an/a

-US$32m

Jun 30 2020n/an/a

-US$41m

Mar 31 2020n/an/a

-US$32m

Dec 31 2019n/an/a

-US$13m

Sep 30 2019n/an/a

US$3m

Jun 30 2019n/an/a

US$4m

Mar 31 2019n/an/a

-US$7m

Dec 31 2018n/an/a

-US$38m

Sep 30 2018n/an/a

-US$48m

Jun 30 2018n/an/a

-US$46m

Mar 31 2018n/an/a

-US$28m

Dec 31 2017US$616kUS$315k

-US$16m

Compensación vs. Mercado: La compensación total de Mike ($USD957.21K) es aproximadamente el promedio para empresas de tamaño similar en el mercado US ($USD740.57K).

Compensación vs. Ingresos: La compensación de Mike ha aumentado mientras la empresa no es rentable.


CEO

Mike Messinger (48 yo)

5.1yrs

Tenure

US$957,211

Compensation

Mr. Michael Messinger, C.P.A., also known as Mike, is President and Chief Executive Officer at ContraFect Corporation since November 15, 2023. He has been Chief Financial Officer of ContraFect Corp. since...


Leadership Team

NamePositionTenureCompensationOwnership
Michael Messinger
CEO, President5.1yrsUS$957.21k0.00021%
$ 1.4
Natalie Bogdanos
General Counsel9.3yrsUS$844.90k0.000010%
$ 0.07
Matthew Salamone
Vice President of Human Resources1.8yrsno datano data
Gary Woodnutt
Senior Vice President of Translational Sciences & Preclinical Development2.5yrsno datano data
William Nichols
Interim Chief Medical Officer1.3yrsno datano data

2.5yrs

Average Tenure

54yo

Average Age

Equipo directivo experimentado: CFRXEl equipo directivo de la empresa se considera experimentado (2.5 años de antigüedad media).


Board Members

NamePositionTenureCompensationOwnership
Sol Barer
Lead Independent Director12.7yrsUS$176.04k0.0095%
$ 64.4
Steven Gilman
Vice Chairman8.6yrsUS$160.54k0.00024%
$ 1.6
Lishan Aklog
Independent Director3.5yrsUS$150.54k0%
$ 0
Roger Pomerantz
Chairman9.7yrsUS$2.23m0.000010%
$ 0.07
Michael Otto
Independent Director9.7yrsUS$160.04k0.000090%
$ 0.6
Leon Smith
Member of Scientific Advisory Boardno datano datano data
Peter Palese
Member of Scientific Advisory Boardno datano datano data
Adolfo Garcia-Sastre
Member of Scientific Advisory Boardno datano datano data
Vincent Fischetti
Chairman of Scientific Advisory Boardno datano datano data
Cary Sucoff
Independent Director13.6yrsUS$155.54k0.00072%
$ 4.9
David Low
Independent Director9.7yrsUS$165.04k0.0043%
$ 29.3
Daniel Capon
Member of Scientific Advisory Boardno datano datano data

9.7yrs

Average Tenure

70yo

Average Age

Junta con experiencia: La junta directiva de CFRX se considera experimentada (9.7 años de antigüedad promedio).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.